Stock Analysis
Labocanna Full Year 2024 Earnings: zł0.015 loss per share (vs zł0.028 loss in FY 2023)
Labocanna (WSE:LCN) Full Year 2024 Results
Key Financial Results
- Net loss: zł309.4k (loss narrowed by 48% from FY 2023).
- zł0.015 loss per share (improved from zł0.028 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Labocanna shares are up 15% from a week ago.
Risk Analysis
You still need to take note of risks, for example - Labocanna has 5 warning signs (and 4 which shouldn't be ignored) we think you should know about.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About WSE:LCN
Labocanna
Engages in the cultivation, production, and distribution of hemp product.